Kuros Biosciences Ltd (OTCPK:CSBTF)
$ 22.72 (0%) Market Cap: 889.20 Mil Enterprise Value: 871.73 Mil PE Ratio: 255.28 PB Ratio: 7.47 GF Score: 71/100

Full Year 2025 Kuros Biosciences AG Earnings Call Transcript

Mar 10, 2026 / 02:00 PM GMT
Release Date Price: $36.78 (+10.10%)

Key Points

Positve
  • Kuros Biosciences Ltd (CSBTF) achieved a 72% revenue growth in 2025, reaching $146.1 million.
  • The company reported its first-time profitability with a net profit of $2.6 million.
  • Kuros Biosciences Ltd (CSBTF) is debt-free with $19.8 million in cash and strong operating cash flow.
  • The company successfully launched new products, including the MIS delivery system, expanding its customer base.
  • Kuros Biosciences Ltd (CSBTF) received multiple health system approvals in the US and MDR approval in the EU, enhancing its commercial footprint.
Negative
  • The company faces external challenges such as US tariffs, which impacted costs by approximately $2 million in 2025.
  • Despite growth, there is a need for continued investment in R&D and infrastructure, which could impact short-term profitability.
  • The transition to US production is expected to incur additional costs and complexities.
  • Kuros Biosciences Ltd (CSBTF) has not provided detailed revenue breakdowns for its different market segments, limiting transparency.
  • The company's growth projections rely heavily on organic growth, which may be challenging in a competitive market.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KURN.S - Kuros Biosciences AG
Full Year 2025 Kuros Biosciences AG Earnings Call
Mar 10, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Chorus Biosciences 4 year 2025 financial report. I will now hand over to Alex Miller from Investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good afternoon or good morning ladies and gentlemen. I welcome you to our presentation of Ko's full year Results 2025. My name is Alex Miller, and I'm responsible for investor relations, and I'm joined today by Chris Behr, our CEO, and Daniel Geiger, our CFO, who will present the full year results. The presentation will be followed by a Q&A session. You can
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot